Cadila Healthcare informs about press release

17 Jul 2018 Evaluate

Cadila Healthcare has informed about press release titled ‘Zydus receives final approval from the USFDA for Clindamycin Phosphate Topical Solution USP’.

The above information is a part of company’s filings submitted to BSE.

 

Zydus Lifesciences Share Price

885.40 -13.35 (-1.49%)
19-Mar-2026 12:45 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1764.10
Dr. Reddys Lab 1267.20
Cipla 1245.60
Zydus Lifesciences 885.40
Lupin 2270.85
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×